Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Invention and uptake of TAVI over the first 20 years

Transcatheter aortic valve implantation (TAVI) is a breakthrough technology to replace the aortic valve in patients with severe aortic stenosis using simple cardiac catheterization instead of thoracic surgery. Initiated 20 years ago by my colleagues and me, TAVI has been performed in >1.5 million patients globally and has profoundly altered the landscape of cardiovascular medicine.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Lababidi, Z., Wu, J. R. & Walls, J. T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am. J. Cardiol. 53, 194–197 (1984).

    CAS  Article  Google Scholar 

  2. Cribier, A. et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1, 63–67 (1986).

    CAS  Article  Google Scholar 

  3. Eltchaninoff, H. et al. Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency. EuroIntervention 1, 438–444 (2006).

    PubMed  Google Scholar 

  4. Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006–3008 (2002).

    Article  Google Scholar 

  5. Cribier, A. et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214–1223 (2006).

    Article  Google Scholar 

  6. Webb, J. G. et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842–850 (2006).

    Article  Google Scholar 

  7. Walther, T. et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 33, 983–988 (2008).

    Article  Google Scholar 

  8. Grube, E. et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69–76 (2007).

    Article  Google Scholar 

  9. Vahanian, A. et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 43, 561–632 (2022).

    Article  Google Scholar 

  10. Durand, E. et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc. Interv. 5, 461–467 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Alain Cribier.

Ethics declarations

Competing interests

A.C. is a consultant for Edwards Lifesciences.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cribier, A. Invention and uptake of TAVI over the first 20 years. Nat Rev Cardiol 19, 427–428 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing